| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/19/2005 | US6881557 Selecting variable region framework sequences from human antibody genes by comparing canonical CDR structure types for corresponding CDRs from a library of human germline antibody sequences |
| 04/19/2005 | US6881552 Human protease associated proteins |
| 04/19/2005 | US6881548 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 04/19/2005 | US6881546 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 04/19/2005 | US6881411 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 04/19/2005 | US6881410 Treatment of E. faecium infection |
| 04/19/2005 | US6881408 Removal of complement factors and lipopolysaccharides (LPS) and, if need be, further sepsis mediators such as TNF and interleukins from body fluids, methods for their production and their use. |
| 04/19/2005 | US6881407 Method for treating hepatitis |
| 04/19/2005 | US6881406 Administering an effective amount of a Chemokine receptor (CCR4) modulating agent, in a dose effective to modulate trafficking of systemic memmory T cells |
| 04/19/2005 | US6881405 Reagents and methods for inducing an immune response to prostate specific antigen |
| 04/19/2005 | US6881401 Methods of treatment of immune system related disorders using Neutrokine-alpha |
| 04/19/2005 | US6881395 Ligand for use as tool in the treatment of tumors in humans |
| 04/14/2005 | WO2005033308A1 Schizophrenia-associated protein and gene coding for the same |
| 04/14/2005 | WO2005033281A2 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 04/14/2005 | WO2005033275A2 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
| 04/14/2005 | WO2005033274A2 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 04/14/2005 | WO2005033267A2 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 04/14/2005 | WO2005033145A1 Antibodies to nik, their preparation and use |
| 04/14/2005 | WO2005033144A2 Tim-3 polypeptides |
| 04/14/2005 | WO2005033143A1 Method of stabilizing antibody and stabilized solution-type antibody preparation |
| 04/14/2005 | WO2005033142A2 Anti-nik antibodies and uses thereof |
| 04/14/2005 | WO2005033136A1 Unique integrin binding site in connective tissue growth factor (ctgf) |
| 04/14/2005 | WO2005033134A2 Secreted protein therapeutics and uses thereof |
| 04/14/2005 | WO2005033133A2 Polynucleotides encoding erbb-2 polypeptides and kits and methods using same |
| 04/14/2005 | WO2005033126A1 Cell surface marker |
| 04/14/2005 | WO2005032589A1 Prevention and treatment for gvhd |
| 04/14/2005 | WO2005032587A1 Vaccine for prevention and treatment of opiate addiction |
| 04/14/2005 | WO2005032578A1 Therapeutic method |
| 04/14/2005 | WO2005032496A2 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 04/14/2005 | WO2005032460A2 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 04/14/2005 | WO2005032454A2 Anti-muc-1 single chain antibodies for tumor targeting |
| 04/14/2005 | WO2005032343A2 Hedgehog signaling in prostate regeneration neoplasia and metastasis |
| 04/14/2005 | WO2005016967A3 Modified human igf-1r antibodies |
| 04/14/2005 | WO2005014649A3 Method for the preparation of molecules having antibody activity |
| 04/14/2005 | WO2005012494A3 Treatment of organ transplant rejection |
| 04/14/2005 | WO2005000194A3 Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same |
| 04/14/2005 | WO2004108157B1 Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders |
| 04/14/2005 | WO2004101739A3 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 04/14/2005 | WO2004097052A3 Methods for prognosis and treatment of solid tumors |
| 04/14/2005 | WO2004096989A3 Single chain antigen-binding polypeptides for polymer conjugation |
| 04/14/2005 | WO2004092215A3 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 04/14/2005 | WO2004091543A3 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells |
| 04/14/2005 | WO2004073624A3 Contraceptive methods and compositions related to proteasomal interference |
| 04/14/2005 | WO2004073393A3 Immunogene adherence and method of making and using same |
| 04/14/2005 | WO2004050683A3 Antibodies directed to tumor necrosis factor and uses thereof |
| 04/14/2005 | WO2004047612A3 Methods of therapy and diagnosis |
| 04/14/2005 | WO2004039307A3 Methods and compositions for diagnosing and treating companion animal cancer |
| 04/14/2005 | WO2004037205A8 LOW DOSE METHODS FOR TREATING DISORDERS IN WHICH TNFα ACTIVITY IS DETRIMENTAL |
| 04/14/2005 | WO2004031105A3 Use of a33 antigens and jam-it |
| 04/14/2005 | WO2004029208A3 Cell separation compositions and methods |
| 04/14/2005 | WO2004020597A3 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 04/14/2005 | WO2004016739A3 Cell modulation using a cytoskeletal protein |
| 04/14/2005 | WO2003083069A3 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 04/14/2005 | WO2003040340A3 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 04/14/2005 | WO2003027228A3 Receptors and membrane-associated proteins |
| 04/14/2005 | US20050080250 Methods of stimulating growth of stromal cells in a human |
| 04/14/2005 | US20050080247 Leinamycin biosynthesis gene cluster and its components and their uses |
| 04/14/2005 | US20050080240 Monoclonal antibody for use as tool in prevention and treatment of viral disease; viricides |
| 04/14/2005 | US20050080239 Immunopolypeptide for use in prevention and treatment of rheumatoid arthritis; immunotherapy |
| 04/14/2005 | US20050080238 Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates |
| 04/14/2005 | US20050080237 Oligomeric molecules and uses thereof |
| 04/14/2005 | US20050080002 Methods for the treatment and prevention of cancer |
| 04/14/2005 | US20050079605 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/14/2005 | US20050079583 Mammalian Zcytor 11 |
| 04/14/2005 | US20050079582 chimeric polypeptide molecules inhibits neoplastic cell growth or inhibits endothelial cell growth |
| 04/14/2005 | US20050079576 Binding polypeptide, for use in the detection and treatment of prostate cancer |
| 04/14/2005 | US20050079575 Human receptor molecules |
| 04/14/2005 | US20050079574 Polypeptide fusion comprising monoclonal antibody complementary determining regions for use as immunotherapeutics and diagnostics |
| 04/14/2005 | US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics |
| 04/14/2005 | US20050079563 Extraction and quanification of vitamins a & d in fluid samples |
| 04/14/2005 | US20050079560 Detection and treatment of cancers of the colon |
| 04/14/2005 | US20050079559 Antibodies specific for phosphorylation sites and screening methods using the same antibodies |
| 04/14/2005 | US20050079550 Isolated protein molecule, flh2882, a GPCR showing homology to the 5HT family of receptors |
| 04/14/2005 | US20050079549 Methods for modeling GPCRs and for producing ligand blocking and receptor activating antibodies for same |
| 04/14/2005 | US20050079543 direct interaction with the ligand-bound receptor and activation of one or more transcription factors; unaffected by the presence or concentration of second messengers; direct interaction with tyrosine kinase domains; absence of interaction with G-proteins; transcriptional stimulation of target genes |
| 04/14/2005 | US20050079541 Immunoadhesin comprising a glycorprotein v1 domain |
| 04/14/2005 | US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents |
| 04/14/2005 | US20050079537 Expression vector comprising nucleotide sequences coding membrane protein for in identifying modulator for prevention and treatment of cell proliferative, nervous system and inflammatory disorders |
| 04/14/2005 | US20050079525 Long wavelength engineered fluorescent proteins |
| 04/14/2005 | US20050079184 Antiinflammatory agents; anticancer agents; neurodegenerative disease; autoimmune diseases ; skin disorders; antiarthritic agents; Alzheimer's disease; antidiabetic agents |
| 04/14/2005 | US20050079183 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds |
| 04/14/2005 | US20050079181 Immunoglobulins from egg yolks; immunization against Eimeria ; human or animal parasiticides; vaccine |
| 04/14/2005 | US20050079179 Compositions and methods for producing vascular occlusion |
| 04/14/2005 | US20050079177 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases |
| 04/14/2005 | US20050079175 Administering receptor ligand protein suspension to prevent binding to lymphocytes |
| 04/14/2005 | US20050079174 Methods and compositions for immunotherapy of B cell involvement in promotion of a disease condition comprising multiple sclerosis |
| 04/14/2005 | US20050079173 Antibody that binds said inhibitor protein; interfering diagnostically or therapeutically with a wnt signal path; treatment of eye disorders, bone disorders, or tumors |
| 04/14/2005 | US20050079172 An isolated cell that expresses an antibody binding to DR4 or DR5, two members of the tumor necrosis factor (TNF) receptor super family |
| 04/14/2005 | US20050079171 Inducing immunology response; administering to mucous membranes |
| 04/14/2005 | US20050079170 Expression vectors coding antigen binding structure; mixture of protein monomers |
| 04/14/2005 | US20050079169 Anti-FcRn antibodies for treatment of auto/allo immune conditions |
| 04/14/2005 | DE10344545A1 New isolated, truncated capsid protein C1 of beak and feather disease virus, useful in vaccines and as a diagnostic agent, and its encoding nucleic acid |
| 04/14/2005 | CA2545248A1 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
| 04/14/2005 | CA2542002A1 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis |
| 04/14/2005 | CA2541823A1 Hypoxia responsive human cngh 0002 genes and polypeptides |
| 04/14/2005 | CA2541535A1 Antibodies to nik, their preparation and use |
| 04/14/2005 | CA2541237A1 Modulation of activin to alter inflammatory responses |
| 04/14/2005 | CA2541018A1 Human prostate cancer cell factor(s) that induce stem cell commitment and osteogenesis |
| 04/14/2005 | CA2541006A1 Tim-3 polypeptides |
| 04/14/2005 | CA2540854A1 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |